vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and WOLVERINE WORLD WIDE INC (WWW). Click either name above to swap in a different company.

WOLVERINE WORLD WIDE INC is the larger business by last-quarter revenue ($517.5M vs $487.7M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). WOLVERINE WORLD WIDE INC runs the higher net margin — 6.1% vs -10.1%, a 16.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 25.5%). WOLVERINE WORLD WIDE INC produced more free cash flow last quarter ($145.6M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 14.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Wolverine World Wide is a global designer, manufacturer and marketer of branded footwear, apparel and accessories. It owns popular brands including Merrell, Sperry, Saucony and Hush Puppies, serving outdoor, casual, workwear and athletic segments via e-commerce, retail stores and global wholesale networks.

CLOV vs WWW — Head-to-Head

Bigger by revenue
WWW
WWW
1.1× larger
WWW
$517.5M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+19.2% gap
CLOV
44.7%
25.5%
WWW
Higher net margin
WWW
WWW
16.3% more per $
WWW
6.1%
-10.1%
CLOV
More free cash flow
WWW
WWW
$214.6M more FCF
WWW
$145.6M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
14.5%
WWW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
WWW
WWW
Revenue
$487.7M
$517.5M
Net Profit
$-49.3M
$31.8M
Gross Margin
47.3%
Operating Margin
-10.1%
9.7%
Net Margin
-10.1%
6.1%
Revenue YoY
44.7%
25.5%
Net Profit YoY
-123.2%
162.8%
EPS (diluted)
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
WWW
WWW
Q1 26
$517.5M
Q4 25
$487.7M
Q3 25
$496.6M
$470.3M
Q2 25
$477.6M
$474.2M
Q1 25
$462.3M
$412.3M
Q4 24
$337.0M
$494.7M
Q3 24
$331.0M
$440.2M
Q2 24
$356.3M
$425.2M
Net Profit
CLOV
CLOV
WWW
WWW
Q1 26
$31.8M
Q4 25
$-49.3M
Q3 25
$-24.4M
$25.1M
Q2 25
$-10.6M
$26.8M
Q1 25
$-1.3M
$12.1M
Q4 24
$-22.1M
$23.1M
Q3 24
$-9.2M
$23.2M
Q2 24
$7.4M
$13.8M
Gross Margin
CLOV
CLOV
WWW
WWW
Q1 26
47.3%
Q4 25
Q3 25
47.5%
Q2 25
47.2%
Q1 25
47.2%
Q4 24
43.4%
Q3 24
24.5%
45.1%
Q2 24
30.3%
43.1%
Operating Margin
CLOV
CLOV
WWW
WWW
Q1 26
9.7%
Q4 25
-10.1%
Q3 25
-4.9%
8.4%
Q2 25
-2.2%
8.6%
Q1 25
-0.3%
4.8%
Q4 24
-6.4%
7.4%
Q3 24
-2.7%
7.9%
Q2 24
2.0%
6.8%
Net Margin
CLOV
CLOV
WWW
WWW
Q1 26
6.1%
Q4 25
-10.1%
Q3 25
-4.9%
5.3%
Q2 25
-2.2%
5.7%
Q1 25
-0.3%
2.9%
Q4 24
-6.6%
4.7%
Q3 24
-2.8%
5.3%
Q2 24
2.1%
3.2%
EPS (diluted)
CLOV
CLOV
WWW
WWW
Q1 26
$0.37
Q4 25
Q3 25
$0.30
Q2 25
$0.32
Q1 25
$0.15
Q4 24
$0.29
Q3 24
$0.28
Q2 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
WWW
WWW
Cash + ST InvestmentsLiquidity on hand
$78.3M
Total DebtLower is stronger
$621.7M
Stockholders' EquityBook value
$308.7M
$408.0M
Total Assets
$541.0M
$1.7B
Debt / EquityLower = less leverage
1.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
WWW
WWW
Q1 26
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Total Debt
CLOV
CLOV
WWW
WWW
Q1 26
$621.7M
Q4 25
Q3 25
$676.4M
Q2 25
$708.5M
Q1 25
$710.8M
Q4 24
$648.0M
Q3 24
$702.8M
Q2 24
$814.7M
Stockholders' Equity
CLOV
CLOV
WWW
WWW
Q1 26
$408.0M
Q4 25
$308.7M
Q3 25
$340.9M
$376.7M
Q2 25
$344.2M
$344.0M
Q1 25
$336.1M
$310.6M
Q4 24
$341.1M
$312.9M
Q3 24
$342.2M
$295.2M
Q2 24
$324.9M
$262.1M
Total Assets
CLOV
CLOV
WWW
WWW
Q1 26
$1.7B
Q4 25
$541.0M
Q3 25
$559.7M
$1.7B
Q2 25
$575.0M
$1.8B
Q1 25
$583.7M
$1.7B
Q4 24
$580.7M
$1.7B
Q3 24
$653.0M
$1.8B
Q2 24
$674.2M
$1.8B
Debt / Equity
CLOV
CLOV
WWW
WWW
Q1 26
1.52×
Q4 25
Q3 25
1.80×
Q2 25
2.06×
Q1 25
2.29×
Q4 24
2.07×
Q3 24
2.38×
Q2 24
3.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
WWW
WWW
Operating Cash FlowLast quarter
$-66.9M
$146.2M
Free Cash FlowOCF − Capex
$-69.0M
$145.6M
FCF MarginFCF / Revenue
-14.1%
28.1%
Capex IntensityCapex / Revenue
0.4%
0.1%
Cash ConversionOCF / Net Profit
4.60×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$125.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
WWW
WWW
Q1 26
$146.2M
Q4 25
$-66.9M
Q3 25
$12.1M
$33.0M
Q2 25
$5.4M
$44.6M
Q1 25
$-16.3M
$-83.8M
Q4 24
$34.8M
$82.4M
Q3 24
$50.0M
$108.2M
Q2 24
$44.8M
$26.7M
Free Cash Flow
CLOV
CLOV
WWW
WWW
Q1 26
$145.6M
Q4 25
$-69.0M
Q3 25
$11.4M
$30.1M
Q2 25
$4.8M
$41.2M
Q1 25
$-16.5M
$-91.4M
Q4 24
$33.3M
$74.4M
Q3 24
$49.6M
$104.1M
Q2 24
$44.4M
$23.7M
FCF Margin
CLOV
CLOV
WWW
WWW
Q1 26
28.1%
Q4 25
-14.1%
Q3 25
2.3%
6.4%
Q2 25
1.0%
8.7%
Q1 25
-3.6%
-22.2%
Q4 24
9.9%
15.0%
Q3 24
15.0%
23.6%
Q2 24
12.5%
5.6%
Capex Intensity
CLOV
CLOV
WWW
WWW
Q1 26
0.1%
Q4 25
0.4%
Q3 25
0.1%
0.6%
Q2 25
0.1%
0.7%
Q1 25
0.0%
1.8%
Q4 24
0.5%
1.6%
Q3 24
0.1%
0.9%
Q2 24
0.1%
0.7%
Cash Conversion
CLOV
CLOV
WWW
WWW
Q1 26
4.60×
Q4 25
Q3 25
1.31×
Q2 25
1.66×
Q1 25
-6.93×
Q4 24
3.57×
Q3 24
4.66×
Q2 24
6.04×
1.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

WWW
WWW

Sales Channel Through Intermediary$230.2M44%
Sales Channel Directly To Consumer$142.6M28%
Work Group$134.0M26%
Other$10.7M2%

Related Comparisons